Move Over, Boston. China Eyes Biotech, Too

摘要

Like so many tech entrepreneurs before them, Wang Xiaodong and John V. Oyler met last fall over dinner to discuss how to start a business. It wasn't the scope of their plans that was unusual, it was the locale. Between bites of stewed beef and honey-soaked cherry tomatoes in a Beijing restaurant, the two discussed how they could mount a small revolution in the pharmaceutical world from China, a country not known for drug development. Their goal: to emulate the success of bio-tech pioneer Genentech and launch a world-class biotech industry in Beijing focusing on cancer drugs.